+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Global Oncology Young Investigator Award

Conquer Cancer Foundation of ASCO

All Conquer Cancer research grant applications are carefully reviewed and evaluated by an independent Grants Selection Committee (Committee) using consistent criteria across all applications for each grant or award type. The Committee scores and ranks the applications, and the highest-scoring applications are funded.

In some circumstances, applications already approved to receive funding based on their high application scores may be matched with Conquer Cancer grants that have additional donor-specified criteria. However, all approved applications will receive Conquer Cancer research grants. In no case will an application not eligible for funding in the initial review process receive a Conquer Cancer research grant.

The Global Oncology Young Investigator Award (GO YIA) provides research funding to early-career investigators to encourage and promote quality research in global oncology and to develop the next generation of researchers to address global health needs. This is a mentored award and the research project is conducted under the guidance of a scientific mentor.

The Global Oncology Young Investigator Award is intended to support:

Research by investigators in low resource settings on scientific questions specific to those settings. This research has potential to offer “reverse innovation” insights that could influence practice in a wide range of practice settings.
Research by investigators in high resource settings on issues in resource-limited settings.
Collaborative research (high and low resource investigators) on questions of shared concern, such as studying a cancer type that affects a small population in the U.S. but is common in another country.

Applicants are encouraged to be innovative in their research proposal. Proposed research projects could include, but are not limited to:

Clinical and translational research
Innovative care delivery
Prevention and palliative care
Implementation research
Health Systems, Outcomes and Economics research related to cancer control and care

Funding Available

The GO YIA is a one-year grant of $50,000. The number of GO YIA grants in each funding cycle is not predetermined by Conquer Cancer. Conquer Cancer is committed to funding the most meritorious applications in all areas of cancer research.

AI Based Application Success Predictor

1️⃣ Clear Clinical Oncology Focus With Strong Patient Impact

ASCO is a clinician-focused organization. Successful applications:

Address meaningful clinical oncology questions

Improve diagnosis, therapy, survivorship, QOL, or equity

Demonstrate a clear and specific benefit to cancer patients

Target unmet needs (rare cancers, poor-prognosis diseases, therapy resistance)

Predictor: Direct relevance to improving patient care is essential.

2️⃣ Strong Mentorship (especially for YIA & CDA)

This is one of the highest-weighted predictors.

Competitive proposals include:

A primary mentor with strong publication record and grant success

A mentoring team with complementary expertise (e.g., biostatistics, translational science, clinical trial design)

A detailed mentoring plan with scheduled meetings and training goals

Departmental commitment (protected time, resources)

Predictor: Strong mentorship is often the difference between funded and unfunded proposals.

3️⃣ Feasible, Well-Designed Study With a Clear Hypothesis

ASCO reviewers expect:

Focused aims (typically 1–2 for YIA, 2–3 for CDA)

A hypothesis that is realistic and testable

A solid methodological plan with controls and statistical justification

Clear patient recruitment or sample-access strategy

Strong feasibility supported by preliminary data

Predictor: High methodological rigor and feasibility.

4️⃣ Strong Preliminary Data (Even for YIA)

Although YIA is an early-career grant, the most competitive submissions show:

Pilot experiments

Feasibility evidence (recruitment logs, pilot cohorts)

Retrospective data supporting the hypothesis

Early biomarker or mechanistic data

Predictor: Credible preliminary support = higher likelihood of funding.

5️⃣ Clear Path Toward Independence (Especially for CDA)

Reviewers ask:

Will this applicant become an independent clinical investigator?

Does the project position them for future NIH/CIHR/DoD/LLS R01-level grants?

Does the department provide protected time and resources?

Does the applicant have a growing publication track record?

Predictor: Evidence of trajectory toward leadership and independence.

6️⃣ Alignment With ASCO Priorities

Conquer Cancer is increasingly focused on:

Health equity in cancer care

Rare cancers and understudied populations

Real-world outcomes

Biomarkers and precision oncology

Survivorship and long-term toxicity

Implementation science

Global oncology (capacity-building, prevention, screening, equitable access)

Predictor: Strong thematic alignment improves competitiveness.

7️⃣ Strong Biostatistical and Analytic Plan

Applications must include:

Sample size calculations or power analysis

Clear primary endpoints

Realistic effect sizes

Plans for missing data, confounders, and sensitivity analyses

Predictor: Statistical rigor is non-negotiable.

8️⃣ Evidence of Institutional Support

Particularly important for CDA.

Strong proposals include:

Letters guaranteeing protected research time

Access to core facilities, clinical trial units, or biorepositories

Clear commitment to candidate development

Predictor: Institutional backing boosts reviewer confidence.

9️⃣ Solid, Justified Budget

ASCO reviewers expect:

Realistic, lean budgets

Clear justification for personnel, assays, sequencing, imaging, etc.

No inflated or poorly explained expenses

Predictor: Budget aligned with aims = stronger overall score.

🚫 COMMON PITFALLS (Why ASCO / Conquer Cancer Applications Fail)

Pitfall	Why It Harms the Proposal
Weak or generic mentoring plan	Major red flag for YIA/CDA
Overly ambitious aims	Feasibility concerns
Lack of preliminary data	Low confidence in success
Poor statistical design	Methodological weakness
Insufficient protected research time	Doubts about execution
Not clinically focused or unclear patient impact	Misaligned with ASCO mission
Weak rationale or unclear hypothesis	Scientific weakness
Ambiguous recruitment or access to patients/samples	Feasibility risk
Poorly written proposal	Hard for reviewers to assess strengths

Specialties

Cancer

Eligibility Requirements

Applicants (Principal Investigators) must meet the following criteria:

Have a doctoral degree (including MD, PhD, MD/PhD, DO, or equivalent doctoral degrees).
In the last year of a fellowship or training program, or in the first two years of a faculty/staff appointment (if in an academic institution) or first two years of employment (if in a non-academic institution) at the time of grant submission. An exception to this window may be granted for applicants in training programs where the protected research time or dedicated research year occurs during the first year of the training program (ex: In surgical oncology fellowship programs, the dedicated research year may occur during the first year of the program). For more information, please contact grants@conquer.org.
Be within 10 years of terminal degree (MD, PhD or equivalent) at the time of application submission. An exception to this criterion may be granted to foreign medical graduates whose medical degree completion may fall outside of the 10-year cutoff. Please see the FAQ for more information or contact grants@conquer.org.
Should demonstrate an interest in oncology or a related branch of science and be working in an oncology setting, but are not required to have oncology-specific training
Be an ASCO member or have submitted a membership application with the grant application. To apply for new membership, or to renew an existing membership, visit asco.org/membership. Please note that ASCO offers free membership for physicians from LMICs.
Must have a contractual obligation with the sponsoring organization (see section for Eligible Organizations).
Be able to commit at least 60% of full-time effort in research (applies to total research, not just the proposed project) during the award period, as confirmed in an institutional Letter of Support.

Applicants who are uncertain about their eligibility are encouraged to contact our grants team for clarification and provide their CV for evaluation.

Eligible Organizations

The sponsoring organization must assure support for the proposed research project. Appropriate institutional commitment to the project includes the provision of adequate staff, facilities, and resources that can contribute to the planning process and implementation of the project. The sponsoring organization must assure to provide protected time to the Principal Investigator. Organizations must have been operating for at least one full year and have an acceptable management structure and processes in place.

Applications may be submitted by the following entities:

Higher Education Institutions
Research Organizations
Government Organizations (may include medical centers and hospitals that have access to resources and infrastructure to support a research project)
Non-profit Organizations (may include medical societies or associations, advocacy organizations, foundations, hospitals)
Non-Governmental Organizations
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Sponsor Details

Sponsor Institute/Organizations: Conquer Cancer Foundation of ASCO

Sponsor Type: Corporate/Non-Profit

Address: 2318 Mill Road, Suite 800 | Alexandria, VA 22314

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity